// Company Overview //
| Stock Name | 密迪斯肌控股有限公司 |
| Stock Code | 08307 |
| Company Full Name | 密迪斯肌控股有限公司 |
| Industry | 居民服務 |
| Principal Activities | 主要於香港提供醫學皮膚護理服務。 |
| Listing Date | 2014-12-18 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港上環永吉街11號永亨保險大廈9樓B室 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | 開曼群島 |
| Listing Method | 發售以供配售 + 發售現有證券 |
| Listing Board | GEM |
| Website | http://www.medicskin.com |
| Share Registrar | 卓佳證券登記有限公司 |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Offer Price | HK$ 0.60 / shares |
| Total Funds Raised | HK$ 60,000,000 |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
| Market Cap at Listing (HKEX) | HK$ 240,000,000 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 2.9 |
| First Day Change | 420.00% |
| First Day Volume | 36200000.0 |
| First Day Turnover | 109685000.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、估計所得款項凈額總額約51.5%或約12.1百萬港元將用作擴大及鞏固我們在香港的地位,其中約7.3百萬港元將用作設立銅鑼灣新Medicskin中心,及約4.8百萬港元將用作搬遷或翻新我們的中環中心;
2、估計所得款項凈額總額約17.9%或約4.2百萬港元將用于購買療程設備,藉以提升我們的服務以及產品供應的質素及種類;
3、估計所得款項凈額總額約21.0%或約4.9百萬港元將用于償還債務;
4、估計所得款項凈額總額約9.6%或約2.3百萬港元將用于提供資金,以供我們用作營運資金及其他一般企業用途。 |
// Underwriting Syndicate //
整体协调人 (2)
申万宏源融资(香港)有限公司
鸿鹏资本证券有限公司
联席账簿管理人 (2)
申万宏源融资(香港)有限公司
鸿鹏资本证券有限公司
// Cornerstone Investors //
This stock has no cornerstone investors.
// Directors & Management //
| Chairman | 江覺亮 |
| Company Secretary | 冼翠碧 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 江覺亮(69.28%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.